ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Revenue

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.1B
P/E ratio
40.2x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202532,570+5.93%
Mar 31, 202430,748-2.57%
Mar 31, 202331,559-2.91%
Mar 31, 202232,506+3.06%
Mar 31, 202131,541-0.68%
Mar 31, 202031,756-7.10%
Mar 31, 201934,182-3.25%
Mar 31, 201835,331-1.00%
Mar 31, 201735,689+0.24%
Mar 31, 201635,602+1.38%
Mar 31, 201535,118+10.11%
Mar 31, 201431,893-0.16%
Mar 31, 201331,944+12.03%
Mar 31, 201228,513

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat